<DOC>
	<DOC>NCT01528241</DOC>
	<brief_summary>This study is designed to characterize the regional distribution of [11C] ABP688 in brain by positron emission tomography (PET).</brief_summary>
	<brief_title>Characterize the Regional Distribution of [11C] ABP688 in Brain by Positron Emission Tomography (PET)</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<criteria>Male and female subjects 5580 (inclusive) Subjects in good health At screening: oral body temperature between 3537.5C systolic blood pressure: 90140 mm Hg diastolic blood pressure: 5090 mm Hg pulse rate: 4090 bpm Female subjects of child bearing potential must have been using a doublebarrier local contraception Postmenopausal women must have had no menstrual bleeding Subjects must have weighed at least 50 kg All subjects must provide informed consent All subjects must have been able to communicate well with investigator Specific to Major depression disorder (MDD) Patients had to show following level of symptomatology: HAMD (17item scale) &gt; 16 CGI &gt; 4 (moderately ill) Specific criteria for healthy volunteers: Presence and/or history of clinically significant major neurological or psychiatric disorder Specific criteria for MDD patients: Presence and/or history of a clinically significant major neurological or psychiatric disorder other than MDD or generalized anxiety disorder Axis I comorbidity was excluded except anxiety spectrum disorders Criteria for both: Smokers Pregnancy Subjects with history of or symptoms/complaints consistent with mild cognitive impairment Use of any psychotropic prescription drugs Coffee consumers more than 6 cups/day Participation in any clinical investigation Donation or loss of 400 mL or more of blood Significant illness within 2 weeks prior to dosing A known hypersensitivity to study drug MRI scan that showed evidence of stroke Any surgical or medical condition which might have significantly altered distribution Clinical evidence of any abnormal lab value History of immunodeficiency disease Positive Hepatitis B surface antigen Presence of contraindications to PET scan investigations Presence of contraindications to MRI investigations Evidence from an Allen test of incomplete communication History of drug or alcohol abuse Current use of anticonvulsant Significant radiation exposure Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>ABP688</keyword>
	<keyword>Tracer</keyword>
	<keyword>Depression</keyword>
</DOC>